Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model

Clinically significant portal hypertension (CSPH), defined as hepatic venous pressure gradient (HVPG) ≥ 10 mm Hg, identifies patients with compensated cirrhosis at a high risk of decompensation. However, HVPG is an invasive and nuanced method. The ANTICIPATE models, which include liver stiffness mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabiee, Anahita, Deng, Yanhong, Ciarleglio, Maria, Chan, Jean L., Pons, Monica, Genesca, Joan, Garcia‐Tsao, Guadalupe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701481/
https://www.ncbi.nlm.nih.gov/pubmed/36214066
http://dx.doi.org/10.1002/hep4.2091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701481/
https://www.ncbi.nlm.nih.gov/pubmed/36214066
http://dx.doi.org/10.1002/hep4.2091

Ejemplares similares